NIRSense
Richmond, Virginia and Cary, North Carolina operating offices; headquarters not assertedFounded 2018
- Neuroimaging
- Wearables
NIRSense develops hospital-quality patient monitors that combine optical sensing to help clinicians assess blood oxygenation and tissue health. Founded to support military medical needs in extreme environments, the company is adapting its rugged monitoring technology for civilian healthcare.
- Founded
- 2018
- Employees
- 11–50
reccy insights
NIRSense’s most notable recent milestones center on deploying its tissue-oxygenation technology in frontline and military-care settings. On Jan 21, 2026, the company and Aspen Medical USA announced a collaboration to deploy and evaluate portable tissue-ischemia monitoring kits with Ukraine’s Ministry of Defence for frontline combat casualty care. The announcement described the delivery of U.S.-developed tissue-oxygenation technology to Ukraine. On May 9, 2026, NIRSense reported deploying its miniaturized tissue-oxygenation monitoring platform, including the Aegis X0 wireless data transmitter, during the US-Philippine Balikatan-26 exercise. The deployment supported real-time tissue-perfusion assessment in battlefield casualty care, and the announcement specifically described support for the U.S. Army in the Indo-Pacific. Together, these milestones show the company applying its monitoring hardware in operational environments and working with an external medical partner. The available company information does not identify awards or executive appointments, and does not disclose funding rounds or financing amounts. The two announced deployments provide concrete examples of field use, but do not by themselves establish the scale of adoption or commercial revenue.
Written by reccy's AI from company sites, press and funding records · updated Oct 2026
What makes NIRSense distinct
- 01Combines near-infrared spectroscopy (NIRS) and photoplethysmography (PPG) in a single lightweight, battery-powered device.
- 02Designed for rugged use, including extreme operating conditions.
- 03Measures systemic oxygen saturation and localized tissue oxygenation to provide complementary patient-status information.
- 04Develops monitoring technology in-house, drawing on a multidisciplinary engineering team and military-application experience.
Technology & products4
- Total Oximetry Monitors
Devices designed for continuous monitoring of arterial and tissue oxygenation in military and civilian healthcare settings.
- Cerebral Oximetry Device
A device for monitoring tissue oxygenation in high-stress environments, particularly military applications.
- NIRSense Technology
A combined PPG and NIRS device for measuring systemic and tissue-specific oxygenation.
+ 1 more: NIRSense tissue oxygenation monitoring platform and Aegis X0 transmitter
Recent updates2
- May 9, 2026Product launch
NIRSense deployed its miniaturized tissue-oxygenation monitoring platform, including the Aegis X0 wireless data transmitter, to support real-time tissue-perfusion assessment during the US-Philippine Balikatan-26 battlefield casualty-care exercise.
prnewswire.com - Jan 21, 2026Partnership
NIRSense and Aspen Medical USA announced a collaboration to deploy and evaluate NIRSense’s portable tissue-ischemia monitoring kits with the Ukraine Ministry of Defence for frontline combat casualty care.
businesswire.com
Similar companies
About NIRSense
- Products
- Total Oximetry Monitors, Cerebral Oximetry Device, NIRSense Technology, NIRSense tissue oxygenation monitoring platform and Aegis X0 transmitter
- Leadership
- Daniel Rodenhaver, Chief Commercial OfficerR. Casey Boutwell, Founder and CEO
- Focus areas
- NeuroTechnology, medical devices, digital health, wearables, hardware, health care, manufacturing, sensor
- Headquarters
- Richmond, Virginia and Cary, North Carolina operating offices; headquarters not asserted
- Founded
- 2018
- Employees
- 11–50
- Patents granted
- 2 (Crunchbase)
- Trademarks
- 1